Site içinde arama yapın

bir ses eklendi Other

2026-07-27 10:52:07 -

Erlotinib HCl Market Revenue to Witness Strong Growth Amid Increasing Cancer Prevalence

According to WiseGuy Reports, the Erlotinib HCl Market generated USD 2,113.7 million in 2024 and expanded to USD 2,263.7 million in 2025. The market is forecast to reach USD 4,500.0 million by 2035, advancing at a CAGR of 7.1%. Rising cancer prevalence, growing demand for targeted oncology therapies, expanding patient awareness, increasing regulatory approvals, and continuous pharmaceutical...

0 Yorumlar 0 hisse senetleri 62 Views 0 önizleme